Literature DB >> 6644499

Mesenchymal hamartoma of the liver.

J G Raffensperger, F Gonzalez-Crussi, T Skeehan.   

Abstract

Mesenchymal hamartoma is a benign, cystic lesion that arises from connective tissues of the portal tracts. It is most common in children under 5 years of age. The diagnosis can be suspected when a relatively asymptomatic child has a large, smooth mass in the liver. Radionuclide scans demonstrate a solitary lesion, and on ultrasound there are cystic spaces and septa. These are perfectly benign lesions and may be simply enucleated.

Entities:  

Mesh:

Year:  1983        PMID: 6644499     DOI: 10.1016/s0022-3468(83)80365-0

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Giant hamartoma of liver mimicking malignancy.

Authors:  K L Narasimharao; K L Narasimhan; S Katariya; S Suri; S Kaushik; S K Mitra
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401

2.  Extrathoracic liver hamartoma.

Authors:  Ebru Yesildag; Yuksel Yeker; Ergun Erdogan; Daver Yeker
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

3.  Cystic mesenchymal hamartoma of the liver.

Authors:  S Federici; G Galli; R Sciutti; D Cuoghi
Journal:  Pediatr Radiol       Date:  1992

Review 4.  Benign liver tumors in pediatric patients - Review with emphasis on imaging features.

Authors:  Liliana Chiorean; Xin-Wu Cui; Andrea Tannapfel; Doris Franke; Martin Stenzel; Wojciech Kosiak; Dagmar Schreiber-Dietrich; Jörg Jüngert; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

5.  Mesenchymal hamartoma of the liver demonstrating peripheral calcification in a 12-year-old boy.

Authors:  Michael A Steiner; Henry W Giles
Journal:  Pediatr Radiol       Date:  2008-07-22

6.  Difficulties in the management of mesenchymal hamartomas.

Authors:  Jonathan Saul Karpelowsky; Andrea Pansini; Colin Lazarus; Heinz Rode; Alistair J W Millar
Journal:  Pediatr Surg Int       Date:  2008-08-28       Impact factor: 1.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.